Shiraki M, Chen J T, Aoki C, Hosoda K
Teijin Bio-medical Research Institute.
Nihon Rinsho. 1994 Sep;52(9):2305-11.
Since osteoporosis has been defined as "state of low bone mass", the bone mineral measurement has been utilized as a golden standard. However some limitations in bone mineral measurement such as expensive machine, very small extent in bone mineral change and/or required long term observation to detect significant change in bone mass, are prohibited extensive use. On the other hand, recent advances in the measurement of bone metabolic markers arrows us to utilize in the diagnosis of osteoporosis as well as in the monitoring of drug efficacy for osteoporosis. Especially in the monitoring of osteoporosis under some treatment, the magnitude of the change in bone metabolic markers are about 10 times higher than that in bone mineral density. Therefore, the measurement of bone metabolic markers may be utilized more widely in the clinical field of not only osteoporosis but also the other metabolic bone diseases in near future.
由于骨质疏松症被定义为“低骨量状态”,骨矿物质测量已被用作金标准。然而,骨矿物质测量存在一些局限性,如机器昂贵、骨矿物质变化程度非常小和/或需要长期观察才能检测到骨量的显著变化,这限制了其广泛应用。另一方面,骨代谢标志物测量的最新进展使我们能够将其用于骨质疏松症的诊断以及骨质疏松症药物疗效的监测。特别是在某些治疗下对骨质疏松症的监测中,骨代谢标志物的变化幅度比骨矿物质密度的变化幅度高约10倍。因此,骨代谢标志物的测量在不久的将来可能会在临床领域得到更广泛的应用,不仅用于骨质疏松症,也用于其他代谢性骨病。